Ethical and Scientific Issues in Studying the Safety of Approved Drugs: A Panel Discussion
The IU Center for Bioethics will co-host a panel presentation on the “Ethical and Scientific Issues in Studying the Safety of Approved Drugs” from 3 to 4 p.m. Wednesday, July 11, 2012 at the Health Information and Translational Science (HITS) Building, Room 1110.
Panel presenters are Sir Alasdair Breckenridge, chair of the Medicines and Healthcare Products Regulatory Agency, London, U.K.; Bruce Psaty, M.D., Ph.D., professor of medicine, epidemiology and health services and co-director of the Cardiovascular Health Research Unit at the University of Washington; and Eric Meslin, Ph.D., director of the IU Center for Bioethics and associate dean for bioethics at the IU School of Medicine. Breckenridge, Psaty and Meslin were members of the Institute of Medicine Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, whose recently published report is the focus of the panel.
This event is co-hosted by the IU Center for Bioethics; Indiana Clinical and Translational Sciences Institute; Regenstrief Institute; Office of the Executive Associate Dean of Research, IU School of Medicine; and the Indiana Institute for Personalized Medicine.